- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.98 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- 4 x BME: BETA-MERCAPTOETHANOL(Non-functional Binders)
BME.2: 6 residues within 4Å:- Chain A: W.173, Y.270, T.272, C.294, A.347
- Ligands: SO4.4
No protein-ligand interaction detected (PLIP)BME.21: 6 residues within 4Å:- Chain B: W.173, Y.270, C.294, A.347
- Ligands: SO4.23, PEG.42
No protein-ligand interaction detected (PLIP)BME.51: 6 residues within 4Å:- Chain C: W.173, Y.270, T.272, C.294, A.347
- Ligands: EDO.58
No protein-ligand interaction detected (PLIP)BME.75: 7 residues within 4Å:- Chain D: W.173, Y.270, T.272, C.294, P.295, A.347
- Ligands: EDO.86
No protein-ligand interaction detected (PLIP)- 12 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 6 residues within 4Å:- Chain A: R.47, A.48, F.49, G.50, A.51, R.266
9 PLIP interactions:9 interactions with chain A- Hydrogen bonds: A:R.47, A:G.50, A:A.51
- Water bridges: A:G.50, A:T.264, A:R.266, A:R.266, A:R.266
- Salt bridges: A:R.266
SO4.4: 6 residues within 4Å:- Chain A: W.173, S.175, K.176, D.177, R.350
- Ligands: BME.2
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:K.176, A:D.177, A:D.177
- Water bridges: A:K.176
- Salt bridges: A:K.176, A:R.350
SO4.22: 4 residues within 4Å:- Chain B: F.49, G.50, A.51, R.266
8 PLIP interactions:8 interactions with chain B- Hydrogen bonds: B:G.50, B:A.51
- Water bridges: B:R.47, B:I.183, B:T.264, B:R.266, B:R.266
- Salt bridges: B:R.266
SO4.23: 7 residues within 4Å:- Chain B: W.173, S.175, K.176, D.177, R.350
- Ligands: BME.21, PEG.42
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:K.176, B:D.177, B:D.177, B:D.177
- Salt bridges: B:R.350
SO4.24: 2 residues within 4Å:- Chain B: R.280, G.281
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:G.281
SO4.52: 6 residues within 4Å:- Chain C: R.47, A.48, F.49, G.50, A.51, R.266
6 PLIP interactions:6 interactions with chain C- Hydrogen bonds: C:R.47, C:G.50, C:A.51
- Water bridges: C:R.266, C:R.266
- Salt bridges: C:R.266
SO4.53: 5 residues within 4Å:- Chain C: F.168, K.169, D.276, S.277, R.280
5 PLIP interactions:5 interactions with chain C- Hydrogen bonds: C:K.169, C:S.277
- Water bridges: C:D.276
- Salt bridges: C:K.169, C:R.280
SO4.54: 2 residues within 4Å:- Chain C: R.280, G.281
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:G.281
SO4.76: 4 residues within 4Å:- Chain D: F.49, G.50, A.51, R.266
6 PLIP interactions:6 interactions with chain D- Hydrogen bonds: D:G.50, D:A.51
- Water bridges: D:I.183, D:R.266, D:R.266
- Salt bridges: D:R.266
SO4.77: 2 residues within 4Å:- Chain D: S.43, S.44
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:S.44, D:S.44
- Water bridges: D:S.43
SO4.78: 6 residues within 4Å:- Chain D: G.167, F.168, K.169, D.276, S.277, R.280
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:K.169, D:S.277
- Water bridges: D:D.276
- Salt bridges: D:R.280
SO4.79: 2 residues within 4Å:- Chain D: R.280, G.281
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:G.281
- 51 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.5: 6 residues within 4Å:- Chain A: N.127, S.128, E.129, L.141, Q.142, T.143
Ligand excluded by PLIPEDO.6: 3 residues within 4Å:- Chain A: F.205, N.349
- Ligands: EDO.65
Ligand excluded by PLIPEDO.7: 1 residues within 4Å:- Chain A: F.49
Ligand excluded by PLIPEDO.8: 4 residues within 4Å:- Chain A: K.261, L.262, K.263, T.264
Ligand excluded by PLIPEDO.9: 2 residues within 4Å:- Chain A: S.43, S.44
Ligand excluded by PLIPEDO.10: 5 residues within 4Å:- Chain A: F.168, K.169, D.276, S.277, R.280
Ligand excluded by PLIPEDO.11: 2 residues within 4Å:- Chain A: T.143, E.145
Ligand excluded by PLIPEDO.12: 2 residues within 4Å:- Chain A: R.116, L.120
Ligand excluded by PLIPEDO.25: 6 residues within 4Å:- Chain B: I.183, V.184, P.185, N.220, E.221
- Ligands: PEG.40
Ligand excluded by PLIPEDO.26: 2 residues within 4Å:- Chain B: F.205, N.349
Ligand excluded by PLIPEDO.27: 5 residues within 4Å:- Chain B: Q.170, D.171, K.274, L.275, D.276
Ligand excluded by PLIPEDO.28: 6 residues within 4Å:- Chain B: R.186, M.187, K.188, K.189, E.190, E.219
Ligand excluded by PLIPEDO.29: 3 residues within 4Å:- Chain B: P.185, M.187, E.258
Ligand excluded by PLIPEDO.30: 4 residues within 4Å:- Chain B: W.85, N.88, F.251
- Chain D: K.89
Ligand excluded by PLIPEDO.31: 6 residues within 4Å:- Chain B: N.127, S.128, E.129, L.141, Q.142, T.143
Ligand excluded by PLIPEDO.32: 3 residues within 4Å:- Chain A: R.372, V.374
- Chain B: D.70
Ligand excluded by PLIPEDO.33: 3 residues within 4Å:- Chain B: N.356, F.358, T.359
Ligand excluded by PLIPEDO.34: 4 residues within 4Å:- Chain B: K.261, L.262, K.263, T.264
Ligand excluded by PLIPEDO.35: 5 residues within 4Å:- Chain B: F.168, K.169, D.276, S.277, R.280
Ligand excluded by PLIPEDO.36: 2 residues within 4Å:- Chain B: T.143, E.145
Ligand excluded by PLIPEDO.37: 2 residues within 4Å:- Chain B: S.43, S.44
Ligand excluded by PLIPEDO.38: 2 residues within 4Å:- Chain B: R.116, L.120
Ligand excluded by PLIPEDO.39: 1 residues within 4Å:- Chain B: K.42
Ligand excluded by PLIPEDO.55: 1 residues within 4Å:- Chain C: R.116
Ligand excluded by PLIPEDO.56: 3 residues within 4Å:- Chain C: P.185, M.187, E.258
Ligand excluded by PLIPEDO.57: 4 residues within 4Å:- Chain A: K.89
- Chain C: W.85, N.88, F.251
Ligand excluded by PLIPEDO.58: 3 residues within 4Å:- Chain C: G.344, A.348
- Ligands: BME.51
Ligand excluded by PLIPEDO.59: 4 residues within 4Å:- Chain C: I.335, Y.368, R.373, Y.375
Ligand excluded by PLIPEDO.60: 2 residues within 4Å:- Chain C: R.367
- Ligands: EDO.61
Ligand excluded by PLIPEDO.61: 4 residues within 4Å:- Chain C: E.364, R.367, Y.375
- Ligands: EDO.60
Ligand excluded by PLIPEDO.62: 3 residues within 4Å:- Chain C: K.42, E.129, K.161
Ligand excluded by PLIPEDO.63: 3 residues within 4Å:- Chain C: D.164, S.165, I.166
Ligand excluded by PLIPEDO.64: 4 residues within 4Å:- Chain C: K.261, L.262, K.263, T.264
Ligand excluded by PLIPEDO.65: 2 residues within 4Å:- Chain C: W.206
- Ligands: EDO.6
Ligand excluded by PLIPEDO.66: 2 residues within 4Å:- Chain C: S.43, S.44
Ligand excluded by PLIPEDO.67: 5 residues within 4Å:- Chain C: R.186, M.187, K.188, K.189, E.190
Ligand excluded by PLIPEDO.80: 1 residues within 4Å:- Chain D: R.13
Ligand excluded by PLIPEDO.81: 4 residues within 4Å:- Chain D: R.13, E.148, A.149, D.150
Ligand excluded by PLIPEDO.82: 2 residues within 4Å:- Chain D: R.116, L.120
Ligand excluded by PLIPEDO.83: 3 residues within 4Å:- Chain D: R.118, A.119, G.121
Ligand excluded by PLIPEDO.84: 4 residues within 4Å:- Chain B: K.89
- Chain D: W.85, N.88, F.251
Ligand excluded by PLIPEDO.85: 1 residues within 4Å:- Chain D: F.49
Ligand excluded by PLIPEDO.86: 5 residues within 4Å:- Chain D: W.173, C.294, G.344, A.348
- Ligands: BME.75
Ligand excluded by PLIPEDO.87: 2 residues within 4Å:- Chain D: V.209, P.229
Ligand excluded by PLIPEDO.88: 3 residues within 4Å:- Chain D: Y.368, R.373, Y.375
Ligand excluded by PLIPEDO.89: 2 residues within 4Å:- Chain D: R.367
- Ligands: EDO.90
Ligand excluded by PLIPEDO.90: 5 residues within 4Å:- Chain D: R.338, E.364, R.367, Y.375
- Ligands: EDO.89
Ligand excluded by PLIPEDO.91: 2 residues within 4Å:- Chain D: K.42, K.161
Ligand excluded by PLIPEDO.92: 3 residues within 4Å:- Chain D: S.165, I.166, G.167
Ligand excluded by PLIPEDO.93: 3 residues within 4Å:- Chain D: G.159, D.164, R.172
Ligand excluded by PLIPEDO.94: 5 residues within 4Å:- Chain D: R.186, M.187, K.188, K.189, E.190
Ligand excluded by PLIP- 22 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.13: 4 residues within 4Å:- Chain A: N.218, N.220, E.221
- Ligands: PEG.15
Ligand excluded by PLIPPEG.14: 2 residues within 4Å:- Chain A: K.42, K.161
Ligand excluded by PLIPPEG.15: 5 residues within 4Å:- Chain A: I.183, V.184, P.185, N.220
- Ligands: PEG.13
Ligand excluded by PLIPPEG.16: 3 residues within 4Å:- Chain A: I.335, R.373, Y.375
Ligand excluded by PLIPPEG.17: 4 residues within 4Å:- Chain A: F.309, Q.313, L.371, R.373
Ligand excluded by PLIPPEG.18: 6 residues within 4Å:- Chain A: R.13, V.136, G.137, E.148, A.149, D.150
Ligand excluded by PLIPPEG.40: 5 residues within 4Å:- Chain B: N.218, E.219, N.220, E.221
- Ligands: EDO.25
Ligand excluded by PLIPPEG.41: 2 residues within 4Å:- Chain B: R.13, R.38
Ligand excluded by PLIPPEG.42: 7 residues within 4Å:- Chain B: W.173, C.294, G.344, A.347, A.348
- Ligands: BME.21, SO4.23
Ligand excluded by PLIPPEG.43: 3 residues within 4Å:- Chain B: R.331, R.373, Y.375
Ligand excluded by PLIPPEG.44: 4 residues within 4Å:- Chain B: F.309, Q.313, L.371, R.373
Ligand excluded by PLIPPEG.45: 4 residues within 4Å:- Chain B: G.192, H.193
- Chain C: G.192, H.193
Ligand excluded by PLIPPEG.46: 6 residues within 4Å:- Chain B: N.88, K.89, S.90
- Chain D: N.88, K.89, S.90
Ligand excluded by PLIPPEG.47: 6 residues within 4Å:- Chain B: R.13, V.136, G.137, E.148, A.149, D.150
Ligand excluded by PLIPPEG.68: 4 residues within 4Å:- Chain C: F.205, A.348, N.349, R.350
Ligand excluded by PLIPPEG.69: 6 residues within 4Å:- Chain A: N.88, K.89, S.90
- Chain C: N.88, K.89, S.90
Ligand excluded by PLIPPEG.70: 7 residues within 4Å:- Chain C: L.73, Q.74, G.75, S.76, R.102
- Chain D: N.97, P.378
Ligand excluded by PLIPPEG.71: 3 residues within 4Å:- Chain C: R.118, A.119, G.121
Ligand excluded by PLIPPEG.72: 3 residues within 4Å:- Chain C: V.131, A.132, S.165
Ligand excluded by PLIPPEG.95: 3 residues within 4Å:- Chain D: V.131, A.132, S.165
Ligand excluded by PLIPPEG.96: 7 residues within 4Å:- Chain C: H.57, L.69, W.377
- Chain D: H.57, R.372, S.376, W.377
Ligand excluded by PLIPPEG.97: 5 residues within 4Å:- Chain A: G.192, H.193
- Chain D: L.191, G.192, H.193
Ligand excluded by PLIP- 2 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
PGE.19: 5 residues within 4Å:- Chain A: R.338, E.364, R.367, Y.375
- Chain B: Q.74
3 PLIP interactions:1 interactions with chain B, 2 interactions with chain A- Hydrogen bonds: B:Q.74, A:R.367, A:R.367
PGE.48: 4 residues within 4Å:- Chain B: W.206
- Chain D: F.205, A.348, N.349
No protein-ligand interaction detected (PLIP)- 3 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
PG4.49: 7 residues within 4Å:- Chain A: Q.74
- Chain B: R.338, E.364, R.367, Y.375, P.378, Q.379
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:R.367, B:R.367, B:Q.379, B:Q.379
PG4.73: 6 residues within 4Å:- Chain C: I.183, V.184, P.185, N.218, N.220, E.221
1 PLIP interactions:1 interactions with chain C- Water bridges: C:E.221
PG4.98: 5 residues within 4Å:- Chain D: V.184, P.185, N.218, N.220, E.221
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:N.218
- Water bridges: D:N.220
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kobayashi, J. et al., Crystal structure of 2-methyl-3-hydroxypyridine-5-carboxylic acid oxygenase. To be Published
- Release Date
- 2013-09-18
- Peptides
- 2-methyl-3-hydroxypyridine-5-carboxylic acid oxygenase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.98 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- 4 x BME: BETA-MERCAPTOETHANOL(Non-functional Binders)
- 12 x SO4: SULFATE ION(Non-functional Binders)
- 51 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 22 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 2 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
- 3 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kobayashi, J. et al., Crystal structure of 2-methyl-3-hydroxypyridine-5-carboxylic acid oxygenase. To be Published
- Release Date
- 2013-09-18
- Peptides
- 2-methyl-3-hydroxypyridine-5-carboxylic acid oxygenase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D